ADHD

ADHD

ADHD

Maternal diabetes is associated with an increased risk of neurodevelopmental disorders in children, according to a review

A review of 202 studies involving more than 56 million mother-child pairs has observed an association between maternal diabetes — including pre-pregnancy and gestational diabetes — and an increased risk of neurodevelopmental disorders in children, such as autism spectrum disorders, attention deficit hyperactivity disorder or intellectual disability. The authors, who publish the results in the journal The Lancet Diabetes & Endocrinology, call for a cautious interpretation of the association, as there is currently little evidence of a causal relationship.

0

Most ADHD drugs, not just stimulants, affect heart rate and blood pressure

An international team has carried out a review of studies and a meta-analysis on the cardiovascular safety of the drugs used to treat ADHD (attention deficit hyperactivity disorder). Their conclusions are that most of them, and not just the stimulants, affect the pulse and blood pressure. According to the authors, who publish the results in the journal The Lancet Psychiatry, although the changes are slight, ‘professionals should monitor blood pressure and pulse in patients with ADHD treated with any pharmacological intervention’.

0

Half of the most viewed TikTok videos about ADHD are not in line with scientific literature

Around half of the 100 most popular videos on TikTok about Attention Deficit Hyperactivity Disorder (ADHD) contain statements that diverge from the scientific literature of reference, according to a study published in PLOS ONE. In addition, the research shows that there are discrepancies between young people and mental health professionals about the educational value of the content about ADHD on this social network.

0

Meta-analysis examines efficacy of ADHD treatments in adults

A meta-analysis published in The Lancet Psychiatry compared various pharmacological and non-pharmacological treatments for Attention Deficit Hyperactivity Disorder (ADHD) in adults. The authors found that only stimulants and atomoxetine effectively reduce symptoms after 12 weeks, but warn that the drugs are not well tolerated by everyone, that they found no evidence that they improve quality of life and that their long-term effects are unclear.

0